LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions.
Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions.
LEO Pharma is headquartered in Denmark and employs around 5,000 people worldwide.
............................................
Disclaimer:
This site is intended for discussions about LEO Pharma and the various initiatives LEO Pharma is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this site. All content must be factual and non-promotional.
LEO Pharma reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma’s values, including
- profane or vulgar language
- insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc.
- commercial or political advertising
- copyright infringements, or any violation of the rights of external parties
- automatically-generated content i.e. spam
- wrong/false statements
Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions.
LEO Pharma is headquartered in Denmark and employs around 5,000 people worldwide.
............................................
Disclaimer:
This site is intended for discussions about LEO Pharma and the various initiatives LEO Pharma is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this site. All content must be factual and non-promotional.
LEO Pharma reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma’s values, including
- profane or vulgar language
- insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc.
- commercial or political advertising
- copyright infringements, or any violation of the rights of external parties
- automatically-generated content i.e. spam
- wrong/false statements
Location: Denmark, Capital Region of Denmark, Måløv
Employees: 5001-10000
Phone: +45 44 94 58 88
Founded date: 1908
Investors 1
| Date | Name | Website |
| - | Nordic Cap... | nordiccapi... |
Mentions in press and media 15
| Date | Title | Description |
| 13.10.2024 | World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives | Help shape the future of women's health by taking the survey and supporting this global campaign in its eleventh year to improve care for at-risk patients. CHAPEL HILL, N.C., Oct. 13, 2024 /PRNewswire/ -- Today is World Thrombosis Day, a gl... |
| 26.07.2024 | Advancing Dermatological Research: The American Skin Association's 2024 Grants** ** | ** The American Skin Association (ASA) has taken a bold step forward in the fight against skin diseases. On July 22, 2024, the ASA announced its 2024 research grants, a lifeline for scientists dedicated to understanding and treating skin co... |
| 26.07.2024 | BioVaxys and American Skin Association: Pioneering Paths in Medical Research** ** | ** In the ever-evolving landscape of medical research, two organizations stand out: BioVaxys Technology Corp. and the American Skin Association (ASA). Each is carving a niche in their respective fields, focusing on innovative solutions for ... |
| 22.07.2024 | AMERICAN SKIN ASSOCIATION ANNOUNCES 2024 RESEARCH GRANTS FOR SKIN CANCER AND DISEASES | NEW YORK, July 22, 2024 /PRNewswire/ -- American Skin Association has announced the names of the three Investigative Scientist Awards. Andrew Ji, MD of Icahn School of Medicine at Mount Sinai was awarded the ASA Sanofi Investigative Scienti... |
| 03.12.2021 | Aqilion strengthens the company’s pipeline through the acquisition of a phase-1 ready anti-inflammatory program from LEO Pharma | Aqilion strengthens the company’s pipeline through the acquisition of a phase-1 ready anti-inflammatory program from LEO Pharma Fri, Dec 03, 2021 14:00 CET AQILION AB (publ) announced today that it has strengthened its pipeline with an inno... |
| 29.09.2021 | LEO Pharma And Veeva Systems Partner For Patient-Centric Digital Trials | Connected solution aims to deliver faster trials and a better patient experience LEO Pharma, a global leader in medical dermatology, and Veeva Systems announced a strategic technology partnership to enable scalable digital trials that are p... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | As interest in climate-tech grows, so are the mega war chests. Paid Content Building a world economy in WordPress From WP Engine Growth equity and buyout investor TPG announced earlier this week that it had raised $5.4 billion to invest in ... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. As interest in climate-tech grows, so are the mega war chests. Growth equity and buyout investor ... |
| 23.03.2021 | LEO Pharma Delivered on Strategic Ambitions and Showed Resilience During COVID-19 Pandemic in 2020 | BALLERUP, Denmark--(BUSINESS WIRE)--Mar 23, 2021-- LEO Pharma net sales recovered from COVID-19 impact during the year, reaching DKK 10.1 billion (-6%) This press release features multimedia. View the full release here: https://www.business... |
| 13.01.2020 | Eli Lilly acquires skin disease-focused Dermira in $1.1B deal | Dermira has one approved product, Qbrexza (glycopyrronium), a medicated cloth used to treat primary axillary hyperhidrosis, or excessive underarm sweating. The lead product candidate in its pipeline is lebrikizumab, a monoclonal antibody in... |
Show more